• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2022 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • SOP Web STAT
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

Voices on the Coronavirus Pandemic from Italy

Voices on the Coronavirus Pandemic from Italy

9/10/2020

About half of the COVID-19 survivors from Bergamo, one of Italy’s coronavirus epicenters, haven’t recovered six months on, providing a stark warning of the pandemic’s lingering aftermath

insider@insider.com (James Pasley)  12 hrs ago

Reporter: Gail S. Thornton, M.A.

  • Six months after the coronavirus hit Bergamo, one of Italy’s early epicenters, nearly half of the survivors haven’t recovered, and are still dealing with a range of problems, according to The Washington Post.

  • Pope John XXIII Hospital infectious disease specialist Serena Venturelli, who has been taking part in a study of COVID-19’s long term effects, told the Post: “Almost half of the patients say no,” when asked if they were cured.

  • Bergamo was closely followed by international media early in the year — army trucks had to drive bodies to morgues outside the region, oxygen had to be piped in for patients, and a harrowing video was released by Sky News showing an overwhelmed ICU dealing with a wave of patients.

  • The long-term effects study began in early May and is based on evidence gathered from former patients visiting the hospital, having their blood drawn, hearts and lungs checked, and discussing how their lives have been since.

  • Venturelli told the Post the doctors felt a “moral obligation” to call the survivors back.

  • Out of the first 750 people who were examined about 30% had breathing difficulties and lung scarring, and another 30% had blood clotting and inflammation issues.

Six months after the coronavirus hit Bergamo, Lombardy’s worst-hit province, which was Italy’s worst hit region, nearly half of the survivors still haven’t recovered, and are dealing with a range of problems.

Pope John XXIII Hospital infectious disease specialist Dr. Serena Venturelli, who is one of the doctors working on a study of COVID-19’s long term effects, told The Washington Post, “Almost half of the patients say no,” when asked if they were cured.

Bergamo is the city where a harrowing video was released in March showing an overwhelmed ICU dealing with a wave of patients.

At one point, so much oxygen was needed for 92 people on ventilators that oxygen had to be piped in using an emergency tank, according to The Post.

It had about 6,000 COVID-19 deaths, filling 10 pages of a local newspaper, according to ABC News.

At another point, the Italian military had to drive bodies to different provinces, because Bergamo’s morgues were overflowing.

The long-term effects study began in early May, and it is based on evidence gathered from twenty people visiting each day, who have their blood drawn, have hearts and lungs checked, and then discuss how their lives have been.

Venturelli told The Post they felt a “moral obligation” to call the survivors back.

“What we saw in March was a tragedy, not a normal hospitalization,” she said.

Dr. Monica Casati, who works in the same hospital as Venturelli, told The Post working in March, hearing people crying and struggling to breathe, was reminiscent of “Dante’s inferno.”

Out of the first 750 people who were examined about 30% had breathing difficulties and lung scarring, and another 30% had blood clotting and inflammation issues.

Doctors from the hospital told The Post there were a wide range of effects, including hair loss, severe fatigue, tingling, depression, memory loss, and pain in the legs.

This is not the first time COVID-19 damage has been analyzed from Bergamo.

In July, Dr. Roberto Cosentini, the head of the emergency department at Papa Giovanni XXIII Hospital told Sky News: “We see a significant proportion of the population with chronic damage from the virus.”

But doctors are not completely disheartened. Patients’ breathing often seems to improve slowly despite permanent lung scarring, and no one has had a fever, The Post reported.

SOURCE

https://www.msn.com/en-us/Health/medical/about-half-of-the-covid-19-survivors-from-bergamo-one-of-italys-coronavirus-epicenters-havent-recovered-six-months-on-providing-a-stark-warning-of-the-pandemics-lingering-aftermath/ar-BB18SezK?ocid=st

###

3/28/2020

Bergamo, Italy

This is the bleak heart of the world’s deadliest coronavirus outbreak.

There have been 9,134 deaths in Italy, more than China and Spain combined, many times more than the United States.

https://www.nytimes.com/interactive/2020/03/27/world/europe/coronavirus-italy-bergamo.html

3/28/2020

Facing Covid-19 in Italy — Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line

List of authors.

  • Lisa Rosenbaum, M.D.

few weeks ago, Dr. D., a middle-aged chief of cardiology at one of the biggest hospitals in northern Italy, developed a fever. Fearing he might have Covid-19, he sought confirmatory testing but was told there weren’t enough tests available for those who hadn’t had demonstrated exposure to an infected person. He was therefore advised to stay home until the fever resolved. He returned to work 6 days later, but 5 days after that, a mild fever recurred, and soon he developed a cough. He again quarantined himself in the basement of his home so as not to expose his family.

With half his hospital’s 1000 beds occupied by patients with Covid-19, Dr. D., who finally received a positive test result on March 10, knows he’s fortunate. About 60 to 90 patients with symptoms suggestive of Covid-19 were presenting to his hospital’s emergency department daily. Noninvasive ventilation was attempted in as many as possible, but the rapidity of respiratory deterioration in the most severely affected patients, including some young ones, was striking and often unforeseeable. “You have no predictive bible to help you,” Dr. D. told me. This uncertainty only heightened the agony of the impossible decisions doctors were facing. “We have to decide who can go forward,” he said.

SOURCE

https://www.nejm.org/doi/full/10.1056/NEJMp2005492

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to print (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 1,254 other subscribers
  • Recent Posts

    • Press Release for Five Bilingual BioMed e-Series January 29, 2023
    • 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
    • Verily announced other organizational changes, 1/13/2023 January 16, 2023
    • Mission 4: Use of Systems Biology for Design of inhibitor of Galectins as Cancer Therapeutic – Strategy and Software December 13, 2022
    • Science Has A Systemic Problem, Not an Innovation Problem December 12, 2022
    • Chemistry Nobelist Carolyn Bertozzi’s years at UC Berkeley October 24, 2022
    • Technion #1 in Europe in Field of AI for 2nd Straight Year October 20, 2022
    • Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners October 11, 2022
    • The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells October 11, 2022
    • Cancer Policy Related News from Washington DC and New NCI Appointments October 4, 2022
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 Amandeep Kaur
    • 1 Aashir Awan, Phd
    • 1 Abhisar Anand
    • 1 Adina Hazan
    • 1 Alan F. Kaul, PharmD., MS, MBA, FCCP
    • 1 alexcrystal6
    • 1 anamikasarkar
    • 1 apreconasia
    • 1 aviralvatsa
    • 1 David Orchard-Webb, PhD
    • 1 danutdaagmailcom
    • 1 Demet Sag, Ph.D., CRA, GCP
    • 1 Dror Nir
    • 1 dsmolyar
    • 1 Ethan Coomber
    • 1 evelinacohn
    • 1 Gail S Thornton
    • 1 Irina Robu
    • 1 jayzmit48
    • 1 jdpmd
    • 1 jshertok
    • 1 kellyperlman
    • 1 Ed Kislauskis
    • 1 larryhbern
    • 1 Madison Davis
    • 1 marzankhan
    • 1 megbaker58
    • 1 ofermar2020
    • 1 Dr. Pati
    • 1 pkandala
    • 1 ritusaxena
    • 1 Rick Mandahl
    • 1 sjwilliamspa
    • 1 Srinivas Sriram
    • 1 stuartlpbi
    • 1 Dr. Sudipta Saha
    • 1 tildabarliya
    • 1 vaishnavee24
    • 1 zraviv06
    • 1 zs22

Powered by WordPress.com.

WPThemes.


%d bloggers like this: